---
$id: https://graph.org.ai/products/commodity/51281609
$type: Product
source: UNSPSC
code: "51281609"
title: "Daptomycin"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Daptomycin

**UNSPSC Code**: 51281609
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NWQ5N31VKK. European Medicines Agency schedules Daptomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06910MIG. Daptomycin generally arises in the molecular formula C72H101N17O26. The term DAPTOMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) DAPTOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule daptomycin under HS 29419000 and SITC 54139. As of Q4 2014, DAPTOMYCIN remains the US FDA Preferred Term for this commodity. Daptomycin bears US NLM identifiers UMLS ID C0057144 and NCI Concept Code C47470. SMILES: O1C(C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CCCCCCCCC)CC2C3C([NH]C2)CCCC3)CC(=O)N)CC(=O)O)C(=O)NCC(=O)NC(CCCN)C(=O)NC(CC(=O)O)C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(CC(=O)O)C)C(=O)NC(CC(=O)C2C(N)CCCC2)C1=O)CO)CC(=O)O)C)C.

